$Clovis Oncology(CLVS.US$https://www.businesswire.com/news/home/20220331005384/en/Clovis-Oncology%E2%80%99s-Rubraca%C2%AE-Rucaparib-Significantly-Improves-Progression-Free-Survival-in-First-line-Maintenance-Treatment-in-Women-with-Ovarian-Cancer-Regardless-of-Their-Biomarker-Status-in-Phase-3-ATHENA-MONO-Trial
1
1
$Romeo Power(RMO.US$
This company is growing ..Announcing it’s progress very quietly . Did some good DD and I’m in ..
This company is growing ..Announcing it’s progress very quietly . Did some good DD and I’m in ..
4
$China SXT Pharmaceuticals(SXTC.US$
Additionally, the company has until June 13, 2022, to regain compliance with Nasdaq's minimum bid requirement of $1.00 or above.
Additionally, the company has until June 13, 2022, to regain compliance with Nasdaq's minimum bid requirement of $1.00 or above.
1